Zydus Wellness Limited has informed the Exchange about Acquisition of Comfort Click Limited, United Kingdom
ZYDUSWELL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.8 pts more than Nifty Smallcap 250 and 10.3 pts more than its Packaged Foods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zydus Wellness, through its wholly owned UK subsidiary Alidac UK Limited, has completed the acquisition of Comfort Click Limited (CCL), a UK-based digital consumer healthcare company in the Vitamins, Minerals and Supplements (VMS) segment. The deal is valued at GBP 239 million in cash (plus a profit ticker from the lock-box date), making it Zydus Wellness's first overseas acquisition. CCL posted revenues of GBP 134 million for FY25 (unaudited), a 5-year CAGR of 57%, with adjusted operating profit of GBP 21 million. The acquisition gives Zydus Wellness a foothold in the UK, Europe, and a platform to expand into the USA, with three brands (WeightWorld, maxmedix, Animigo) spanning adult, kids, and pet nutrition segments sold largely through e-commerce and D2C channels. The deal is expected to be Cash EPS accretive, and the existing CCL management will continue to run operations with part of their proceeds reinvested in growth shares tied to performance milestones.
This is a sizeable international acquisition (roughly ₹2,600+ crore at current GBP/INR rates) that expands Zydus Wellness into the high-growth global VMS market and digital wellness space. In the near term, shareholders may weigh the cash outflow and integration risks against the long-term growth optionality in a USD 50–60 billion addressable market; the EPS-accretive guidance and rollover management structure are supportive signals for value creation.